TickerFactsScreenerDevelopers

BioAtla, Inc. (BCAB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $10.86M2019: $3.70M2020: $238.60M2021: $244.98M2022: $215.51M2023: $111.47M2024: $49.05M2025: $7.12M$7.12M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$7.12M-85.5%
2024$49.05M-56.0%
2023$111.47M-48.3%
2022$215.51M-12.0%
2021$244.98M+2.7%
2020$238.60M+6341.8%
2019$3.70M-65.9%
2018$10.86M—